Cytosorbents Corp at UBS Global Healthcare Virtual Conference Transcript
Good afternoon. Thank you for coming to the 2021 Virtual UBS Global Healthcare Conference. My name is Tim. I'm happy to be your host for this session. Our next presenter will be Dr. Phillip Chan from CytoSorbents. Q&A session will follow immediately after the presentation. (Operator Instructions)
We now turn it over to Dr. Chan. Thank you.
Thank you very much, Tim, and thank you very much for the invitation to be here today. It's a pleasure to introduce the CytoSorbents story to new investors. If you can follow along with the presentation, let's go Slide 2. As a publicly traded company, please let me remind you of our safe harbor statement for forward-looking statements.
On Slide 3. CytoSorbents is leading the prevention or treatment of life-threatening inflammation, cytokine storm and other deadly conditions in the ICU and cardiac surgery using our CytoSorb blood purification technology.
On the next slide. CytoSorbents is a rapidly growing, international,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |